Inactive Instrument

Resonate Blends Inc. Stock Other OTC

KOAN

US76090M1027

Valuation: Resonate Blends Inc.

Market Cap	834K 730K 673K 622K 1.18M 79.55M 1.2M 8.04M 3.16M 39.19M 3.13M 3.06M 135M	P/E 2023	-0.56x	P/E 2024	-0.16x
Enterprise Value	4.68M 4.1M 3.78M 3.49M 6.62M 447M 6.73M 45.15M 17.73M 220M 17.59M 17.2M 756M	EV / Sales 2023	211x	EV / Sales 2024	2.22x
Free-Float	98.5%	Yield 2023 *	-	Yield 2024	-

* Estimated data More valuation ratios

Latest news : Resonate Blends Inc.

02-09	MedWellAI Inc. signed a letter of intent to acquire Resonate Blends, Inc. from FirstFire Capital Management LLC.	CI
25-09-16	Revive Regenerative, Inc signed a letter of intent to acquire Resonate Blends, Inc. in a reverse merger transaction.	CI
25-06-16	Resonate Blends, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
25-06-10	Resonate Blends, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25-06-09	Resonate Blends, Inc. Auditor Raises 'Going Concern' Doubt	CI
25-03-14	Resonate Blends, Inc. Announces CEO Changes	CI
25-03-14	Resonate Blends, Inc. Announces Executive Changes	CI
24-11-26	Resonate Blends, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
24-08-21	Resonate Blends, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
24-06-27	Resonate Blends, Inc. has Changed its Name to Apollo Biowellness, Inc	CI
24-05-20	Resonate Blends, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
24-04-16	Resonate Blends, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
24-04-15	Resonate Blends, Inc. Auditor Raises 'Going Concern' Doubt	CI

More news

Press Releases: Resonate Blends Inc.

04-08	Apollo Biowellness, Inc., Update of Take-Over by MedwellAI, Inc.	NE
02-10	Apollo Biowellness Executes Letter Of Intent with Medwell AI, Inc.	NE
02-06	Apollo Biowellness, Inc., Announces Termination of Distribution Agreement with Revive Regenerative, Inc.	NE
01-07	Apollo Biowellness, Inc., Announces Expiration of Letter of Intent, Negotiations Continue	NE
25-10-29	Apollo Biowellness, Inc., Corporate Status and Merger Update	NE

More press releases

Managers and Directors: Resonate Blends Inc.

Manager	Title	Age	Since
James Zimbler CEO	Chief Executive Officer	56	2025-03-04

Director	Title	Age	Since
James Morrison CHM	Chairman	65	-
James Zimbler BRD	Director/Board Member	56	2024-03-13

More insiders

Apollo Biowellness, Inc., and its subsidiary, Evolutionary Biologics, Inc., is engaged in the discovery, development and marketing of products designed to better mankind. The Company is engaged in the field of regenerative medicine using biologic-based products. Its products are intended to market under third-party label exemptions. The Company is focused on marketing licensed patent-pending natural stem cell mobilizing agents capable of enhancing each individual's ability to mobilize their own adult stem cells from their bone marrow. It is licensed under a patent-pending application to market a dual-acting all-natural diet aid designed to help control hunger through normal body signals to the brain and stomach. Its products are being developed for consumer and professional markets.

Employees

Sector

Pharmaceuticals

More about the company

Google lets you customize your preferred sources.

Choose MarketScreener

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
RESONATE BLENDS INC.	-.--%	-2.46%	-	-	234K
REGENERON PHARMACEUTICALS, INC.	-0.51%	+1.57%	+17.05%	-7.30%	67.61B
UCB	-5.16%	-8.63%	+38.70%	+203.59%	51.6B
SAMSUNG BIOLOGICS CO.,LTD.	+5.28%	+39.50%	+39.50%	+39.50%	43B
CSL LIMITED	-2.10%	+0.89%	-48.99%	-53.63%	40.94B
BIOGEN INC.	+0.12%	-7.85%	+48.39%	-28.83%	29.4B
MODERNA, INC.	-10.83%	-14.41%	+102.94%	-44.10%	27.09B
INCYTE CORPORATION	-1.53%	-0.13%	+70.16%	+85.73%	23.32B
INNOVENT BIOLOGICS, INC.	+3.88%	+2.16%	+11.36%	+192.66%	19.92B
SWEDISH ORPHAN BIOVITRUM AB	-1.59%	-1.63%	+64.87%	+130.98%	16.91B
Average	-1.24%	-3.02%	+38.22%	+57.62%	35.53B
Weighted average by Cap.	-1.36%	-2.83%	+31.31%	+48.54%

	2023	2024
Net sales	16.47K 14.4K 13.29K 12.27K 23.28K 1.57M 23.68K 159K 62.34K 774K 61.83K 60.49K 2.66M	1.9M 1.66M 1.53M 1.41M 2.68M 181M 2.73M 18.28M 7.18M 89.09M 7.12M 6.96M 306M
Net income	-1.42M -1.24M -1.14M -1.06M -2M -135M -2.04M -13.65M -5.36M -66.53M -5.32M -5.2M -229M	-2.13M -1.87M -1.72M -1.59M -3.02M -203M -3.07M -20.56M -8.08M -100M -8.01M -7.84M -345M
Net Debt	2.51M 2.19M 2.02M 1.87M 3.55M 239M 3.61M 24.19M 9.5M 118M 9.42M 9.22M 405M	3.85M 3.37M 3.11M 2.87M 5.44M 367M 5.53M 37.11M 14.57M 181M 14.45M 14.14M 622M

Resonate Blends Inc. Stock Other OTC

Stocks